Back
Moleculin Biotech, Inc. 10K Form
Sell
14
MBRX
Moleculin Biotech, Inc.
Last Price:
$7.37
Seasonality Move:
-20.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MBRX News And Ratings
See the #1 stock for the next 7 days that we like better than MBRX
MBRX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-13.60 |
| Price / Book: | 485.33 |
Profitability
| EPS (TTM): | -43.93690 |
|---|---|
| Net Income (TTM): | $-41.4M |
| Gross Margin: | $-126K |
| Return on Equity: | -552.21% |
| Return on Assets: | -213.6% |
Moleculin Biotech, Inc. Earnings Forecast
Key Moleculin Biotech, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Moleculin Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MBRX |
| CUSIP: | 60855D |
| Website: | moleculin.com |
Debt
| Debt-to-Equity Ratio: | -0.01 |
|---|---|
| Current Ratio: | 1.39 |
| Quick Ratio: | 1.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MBRX Technical Analysis vs Fundamental Analysis
Sell
14
Moleculin Biotech, Inc. (MBRX)
is a Sell
Is Moleculin Biotech, Inc. a Buy or a Sell?
-
Moleculin Biotech, Inc. stock is rated a SellThe current Moleculin Biotech, Inc. [MBRX] share price is $7.24. The Score for MBRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.